323 related articles for article (PubMed ID: 30771780)
1. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
Zhu P; Du XL; Zhu JJ; Esquenazi Y
J Neurosurg; 2019 Feb; 132(2):491-502. PubMed ID: 30771780
[TBL] [Abstract][Full Text] [Related]
2. The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database.
Zhu P; Pichardo-Rojas PS; Dono A; Tandon N; Hadjipanayis CG; Berger MS; Esquenazi Y
J Neurooncol; 2024 May; 168(1):77-89. PubMed ID: 38492191
[TBL] [Abstract][Full Text] [Related]
3. Definitive chemoradiation at high volume facilities is associated with improved survival in glioblastoma.
Haque W; Verma V; Butler EB; Teh BS
J Neurooncol; 2017 Oct; 135(1):173-181. PubMed ID: 28687924
[TBL] [Abstract][Full Text] [Related]
4. Impact of facility type and volume in low-grade glioma outcomes.
Zhu P; Du XL; Blanco AI; Ballester LY; Tandon N; Berger MS; Zhu JJ; Esquenazi Y
J Neurosurg; 2019 Sep; 133(5):1313-1323. PubMed ID: 31561219
[TBL] [Abstract][Full Text] [Related]
5. Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma.
Hauser A; Dutta SW; Showalter TN; Sheehan JP; Grover S; Trifiletti DM
J Clin Neurosci; 2018 Jan; 47():103-110. PubMed ID: 29113851
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.
Trifiletti DM; Alonso C; Grover S; Fadul CE; Sheehan JP; Showalter TN
World Neurosurg; 2017 Jul; 103():330-340. PubMed ID: 28427986
[TBL] [Abstract][Full Text] [Related]
7. Patterns of care and outcomes of chemoradiation versus radiation alone for MGMT promoter unmethylated glioblastoma.
Lee A; Malakhov N; Sheth N; Wang A; Han P; Schreiber D
Clin Neurol Neurosurg; 2018 Jul; 170():127-131. PubMed ID: 29777945
[TBL] [Abstract][Full Text] [Related]
8. Survival trends in glioblastoma and association with treating facility volume.
Aulakh S; DeDeo MR; Free J; Rosenfeld SS; Quinones-Hinojosa A; Paulus A; Manna A; Manochakian R; Chanan-Khan AA; Ailawadhi S
J Clin Neurosci; 2019 Oct; 68():271-274. PubMed ID: 31133366
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
10. Association between hospital volume and receipt of treatment and survival in patients with glioblastoma.
Koshy M; Sher DJ; Spiotto M; Husain Z; Engelhard H; Slavin K; Nicholas MK; Weichselbaum RR; Rusthoven C
J Neurooncol; 2017 Dec; 135(3):529-534. PubMed ID: 28836140
[TBL] [Abstract][Full Text] [Related]
11. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
12. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
13. Counseling Patients with a Glioblastoma Amenable Only for Subtotal Resection: Results of a Multicenter Retrospective Assessment of Survival and Neurologic Outcome.
Coburger J; Segovia J; Ganslandt O; Ringel F; Wirtz CR; Renovanz M
World Neurosurg; 2018 Jun; 114():e1180-e1185. PubMed ID: 29621607
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma.
Jin MC; Wu A; Xiang M; Azad TD; Soltys SG; Li G; Pollom EL
World Neurosurg; 2019 Aug; 128():e217-e224. PubMed ID: 31009783
[TBL] [Abstract][Full Text] [Related]
15. The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma.
Lopez Ramos C; Brandel MG; Steinberg JA; Wali AR; Rennert RC; Santiago-Dieppa DR; Sarkar RR; Pannell JS; Murphy JD; Khalessi AA
J Neurooncol; 2019 Jan; 141(1):159-166. PubMed ID: 30460629
[TBL] [Abstract][Full Text] [Related]
16. Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer-accredited hospitals in the United States.
Goyal A; Zreik J; Brown DA; Kerezoudis P; Habermann EB; Chaichana KL; Chen CC; Bydon M; Parney IF
J Neurosurg; 2022 Jul; 137(1):32-41. PubMed ID: 34767534
[TBL] [Abstract][Full Text] [Related]
17. Extent of resection and survival outcomes of geriatric patients with glioblastoma: Is there benefit from aggressive surgery?
Lopez-Rivera V; Dono A; Lewis CT; Chandra A; Abdelkhaleq R; Sheth SA; Ballester LY; Esquenazi Y
Clin Neurol Neurosurg; 2021 Mar; 202():106474. PubMed ID: 33454497
[TBL] [Abstract][Full Text] [Related]
18. Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival.
Haque W; Verma V; Butler EB; Teh BS
Dis Esophagus; 2019 Apr; 32(4):. PubMed ID: 30052835
[TBL] [Abstract][Full Text] [Related]
19. Survival improvements with adjuvant therapy in patients with glioblastoma.
Jayamanne D; Wheeler H; Cook R; Teo C; Brazier D; Schembri G; Kastelan M; Guo L; Back MF
ANZ J Surg; 2018 Mar; 88(3):196-201. PubMed ID: 28922698
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
